Can Antihypertensive Treatment Benefit Persons Without Hypertension?

Kuritzky, Louis
April 2011
Internal Medicine Alert;4/29/2011 Supplement, p64
The article discusses a meta-analysis of a clinical trial on the benefits of treating prehypertension with antihypertensive drugs wherein it reveals that patients at high risk of cardiovascular disease have decreased risk of stroke.


Related Articles

  • Long-Term Antioxidant Supplementation Improves Arterial Health. Dye, D. // Life Extension;Oct2010, Vol. 16 Issue 10, p21 

    The article discusses research which was published in "Nutrition end Metabolism" and found that supplementing with four antioxidants improved arterial elasticity and HDL cholesterol while reducing hemoglobin A1c in men and women at risk of cardiovascular disease.

  • Is new science driving practice improvements and better patient outcomes? Applications for cardiac rehabilitation. Myers, Jonathan; Herbert, William; Ribisl, Paul; Franklin, Barry // Clinical & Investigative Medicine;Dec2008, Vol. 31 Issue 6, pE400 

    Evidence from many clinical trials in recent years suggests that a large "treatment gap" exists between recommended therapies and the care that patients actually receive. This gap has been particularly apparent in the area of primary and secondary prevention of cardiovascular disease. In this...

  • Two diets beneficial for patients at risk for CVD. Haigh, Christen; Redberg, Rita F. // Cardiology Today;Apr2008, Vol. 11 Issue 4, p16 

    The article reports that low-fat and Mediterranean-style diets can reduce cardiovascular heart disease risk. Katherine R. Tuttle, medical and scientific director at the University of Washington School of Medicine, says that survival rate free of major complication after myocardial infarction was...

  • Aspirin in the primary prevention of cardiovascular disease in the Women's Health Study: Effect of noncompliance. Cook, Nancy; Cole, Stephen; Buring, Julie // European Journal of Epidemiology;Jun2012, Vol. 27 Issue 6, p431 

    Randomized evidence for aspirin in the primary prevention of cardiovascular disease (CVD) among women is limited and suggests at most a modest effect for total CVD. Lack of compliance, however, can null-bias estimated effects. We used marginal structural models (MSMs) to estimate the etiologic...

  • Dronedarone: a guide to its use in atrial fibrillation.  // Drugs & Therapy Perspectives;Mar2010, Vol. 26 Issue 3, p1 

    Dronedarone is a new option to treat patients with atrial fibrillation (AF). In clinical trials in patients with AF, it prevented AF recurrence, lowered cardiovascular mortality and morbidity, and reduced ventricular heart rate.

  • The role of angiotensin receptor blockers in the prevention of cardiovascular and renal disease: time for reassessment? Fuchs, Fl├ívio Danni // Evidence Based Medicine;Apr2013, Vol. 18 Issue 2, p44 

    Angiotensin receptor blockers (ARB) have been recommended as a first option for the management of hypertension by guidelines, particularly in patients at high cardiovascular risk. The preference for ARB in these conditions is based on their neutral metabolic effects, and on direct cardiac and...

  • Do Omega-3 Polyunsaturated Fatty Acids Prevent Cardiovascular Disease? A Review of the Randomized Clinical Trials. Kimmig, Lucas M.; Karalis, Dean G. // Lipid Insights;2013, Issue 6, p13 

    Fish oil is rich in the omega-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Numerous epidemiological studies and several large randomized clinical trials have shown that modest doses of omega-3 PUFAs significantly reduce the risk of unstable...

  • Registrar: MRCGP Exam update - Secondary stroke prevention. Newson, Louise // GP: General Practitioner;1/19/2007, p49 

    The article discusses issues related to secondary stroke prevention. According to an analysis of GMS quality framework data on stroke in the National Audit Office report "Reducing Brain Damage: Faster Access to Better Stroke Care," overall general practitioner (GP) care of stroke patients has...

  • Invited Commentary: How Far Can Epidemiologists Get with Statistical Adjustment? Petitti, Diana B.; Freedman, David A. // American Journal of Epidemiology;Sep2005, Vol. 162 Issue 5, p415 

    The article presents a commentary on a paper which explored the reasons for the differences in estimates of coronary heart disease, stroke and venous thromboembolism risk for hormones between the Women's Health Initiative (WHI) clinical trial and the WHI observational study. It discusses the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics